IBM Research will undertake research with Melanoma Institute Australia to help further advance the identification of melanoma using cognitive technology. This research builds on IBM’s existing research agreement with MoleMap, which uses advanced visual analytics to analyze more than 40,000 data sets including images and text. IBM Research plans to analyze dermatological images of skin […]
A transcript of Biden’s speech at the National Cancer Moonshot Summit at Howard University.
RESEARCH!AMERICA launched its Campaign for Cures 2016 election blog and an online interactive map featuring hundreds of quotes on medical progress from candidates across the political spectrum running for national office. Managed by former USA Today senior editor and health reporter Janice Lloyd, the blog features election news, survey data, commentary and analysis of presidential […]
FDA granted a fourth Breakthrough Therapy Designation to Imbruvica (ibrutinib) as a potential treatment of chronic graft-versus-host-disease after failure of one or more lines of systemic therapy. The agency also granted the therapy Orphan Drug Designation for the condition. The request was based on preliminary clinical data from a phase Ib/II study evaluating the safety […]
THE AMERICAN CANCER SOCIETY plans to double its annual funding for research by 2021. The society made the announcement in conjunction with Vice President Biden’s National Cancer Moonshot Summit at Howard University in Washington, D.C. ACS plans to increase its annual research investment to approximately $240 million by 2021. The organization currently spends about $100 […]
JOEL KATZ was honored by City of Hope with the Spirit of Life Award. Katz, an entertainment attorney, is chair of the Global Entertainment and Media Practice of Greenberg Traurig, and was recognized for his work in the entertainment industry. Katz will be presented with the award at a gala in Los Angeles Nov. 10. […]
FIRAS ELADOUMIKDACHI was named program director for the Rutgers Cancer Institute of New Jersey at Hamilton. He will be responsible for clinical leadership of the oncology service line at RWJ Hamilton including medical, surgical and radiation oncology. Eladoumikdachi is an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School. He has been with […]
STEPHEN BURLEY was named as co-program leader of the Cancer Pharmacology Research Program at Rutgers Cancer Institute of New Jersey. Burley will work with co-program leader X.F. Steven Zheng, a university professor at Rutgers Robert Wood Johnson Medical School, in determining the mode of action and mechanism of resistance to anti-cancer agents and developing novel […]
Richard Pazdur, currently the director of the FDA Office of Hematology and Oncology Products, will serve as acting director of the newly formed FDA Oncology Center of Excellence.
Vice President Joe Biden announced the formation of the FDA Oncology Center of Excellence, which is intended to consolidate the agency's cancer portfolio and streamline regulatory pathways for cancer-related drugs, biologics, and devices.
